Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    April 2021
  1. ISAILOVIC N, Ceribelli A, Cincinelli G, Vecellio M, et al
    Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Apr 26. doi: 10.1111/cei.13609.
    PubMed     Abstract available


    January 2021
  2. RINCON-AREVALO H, Rojas M, Vanegas-Garcia A, Munoz-Vahos C, et al
    Atypical phenotype and response of B cells in patients with seropositive rheumatoid arthritis.
    Clin Exp Immunol. 2021 Jan 18. doi: 10.1111/cei.13576.
    PubMed     Abstract available


    November 2020
  3. KHAN S, Longhurst H
    Epigenetic alterations on C1-inhibitor expression may influence hereditary angioedema attack frequency and C4 levels: Comment on: Karagianni P, Goules AV, Tzioufas AG. Epigenetic alterations in Sjogren's syndrome patient saliva.
    Clin Exp Immunol. 2020;202:144-145.
    PubMed     Abstract available


  4. KARAGIANNI P, Goules AV, Tzioufas AG
    Epigenetic alterations in Sjogren's syndrome patient saliva.
    Clin Exp Immunol. 2020;202:137-143.
    PubMed     Abstract available


    October 2020
  5. HALPERT G, Katz I, Shovman O, Tarasov S, et al
    IVIG ameliorate inflammation in collagen induced arthritis- projection for IVIG therapy in rheumatoid arthritis.
    Clin Exp Immunol. 2020 Oct 6. doi: 10.1111/cei.13532.
    PubMed     Abstract available


  6. WANG X, Sun L, He N, An Z, et al
    Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis.
    Clin Exp Immunol. 2020 Oct 3. doi: 10.1111/cei.13527.
    PubMed     Abstract available


    June 2020
  7. CANAVAN M, Marzaioli V, McGarry T, Bhargava V, et al
    Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.
    Clin Exp Immunol. 2020 Jun 17. doi: 10.1111/cei.13479.
    PubMed     Abstract available


    April 2020
  8. LUBBERS R, Oostindie SC, Dijkstra DJ, Parren PWHI, et al
    Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
    Clin Exp Immunol. 2020;200:1-11.
    PubMed     Abstract available


    January 2020
  9. DE BONT CM, Eerden N, Boelens WC, Pruijn GJM, et al
    Neutrophil proteases degrade autoepitopes of NET-associated proteins.
    Clin Exp Immunol. 2020;199:1-8.
    PubMed     Abstract available


    October 2019
  10. SVARD A, Roos Ljungberg K, Brink M, Martinsson K, et al
    Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives.
    Clin Exp Immunol. 2019 Oct 12. doi: 10.1111/cei.13381.
    PubMed     Abstract available


    June 2019
  11. OI K, Tokunaga T, Kuranobu T, Yukawa K, et al
    Tumour necrosis factor alpha augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
    Clin Exp Immunol. 2019;196:392-402.
    PubMed     Abstract available


  12. HAGERT C, Siitonen R, Li XG, Liljenback H, et al
    Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure.
    Clin Exp Immunol. 2019;196:383-391.
    PubMed     Abstract available


    May 2019
  13. GUAN L, Yu D, Wu GH, Ning HJ, et al
    Vasoactive intestinal peptide is required in the maintenance of immune regulatory competency of immune regulatory monocytes.
    Clin Exp Immunol. 2019;196:276-286.
    PubMed     Abstract available


    April 2019
  14. SHIMIZU T, Nakamura H, Takatani A, Umeda M, et al
    Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjogren's syndrome patients.
    Clin Exp Immunol. 2019;196:39-51.
    PubMed     Abstract available


    March 2019
  15. IVANCHENKO M, Aqrawi LA, Bjork A, Wahren-Herlenius M, et al
    FoxP3(+) CXCR5(+) CD4(+) T cell frequencies are increased in peripheral blood of patients with primary Sjogren's syndrome.
    Clin Exp Immunol. 2019;195:305-309.
    PubMed     Abstract available


  16. FONSECA VR, Graca L
    Contribution of FoxP3(+) Tfr cells to overall human blood CXCR5(+) T cells.
    Clin Exp Immunol. 2019;195:302-304.
    PubMed     Abstract available


    January 2019
  17. STEEN-LOUWS C, Hartgring SAY, Popov-Celeketic J, Lopes AP, et al
    IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.
    Clin Exp Immunol. 2019;195:1-9.
    PubMed     Abstract available


  18. OSADA Y, Horie Y, Nakae S, Sudo K, et al
    STAT6 and IL-10 are required for the anti-arthritic effects of Schistosoma mansoni via different mechanisms.
    Clin Exp Immunol. 2019;195:109-120.
    PubMed     Abstract available


    December 2018
  19. WEHR P, Purvis H, Law SC, Thomas R, et al
    Dendritic cells, T cells and their interaction in Rheumatoid arthritis.
    Clin Exp Immunol. 2018 Dec 27. doi: 10.1111/cei.13256.
    PubMed     Abstract available


    October 2018
  20. FEARON U, Hanlon MM, Wade SM, Fletcher J, et al
    Altered metabolic pathways regulate synovial inflammation in Rheumatoid Arthritis.
    Clin Exp Immunol. 2018 Oct 25. doi: 10.1111/cei.13228.
    PubMed     Abstract available


  21. HU X, Tang J, Hu X, Bao P, et al
    Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast-like synoviocytes.
    Clin Exp Immunol. 2018 Oct 3. doi: 10.1111/cei.13220.
    PubMed     Abstract available


    September 2018
  22. LIN J, He Y, Wang B, Xun Z, et al
    Blocking of YY1 Reduce Neutrophil Infiltration by Inhibiting IL-8 Production via PI3K-Akt-mTOR Signaling Pathway in Rheumatoid Arthritis.
    Clin Exp Immunol. 2018 Sep 19. doi: 10.1111/cei.13218.
    PubMed     Abstract available


  23. GUO C, Fu R, Wang S, Huang Y, et al
    NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.
    Clin Exp Immunol. 2018 Sep 16. doi: 10.1111/cei.13167.
    PubMed     Abstract available


  24. LUO Q, Zhang L, Li X, Fu B, et al
    Identification of circular RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for Rheumatoid Arthritis.
    Clin Exp Immunol. 2018 Sep 14. doi: 10.1111/cei.13181.
    PubMed     Abstract available


    August 2018
  25. KASTBOM A, Roos Ljungberg K, Ziegelasch M, Wettero J, et al
    Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
    Clin Exp Immunol. 2018 Aug 23. doi: 10.1111/cei.13206.
    PubMed     Abstract available


    July 2018
  26. KOMATSU N, Takayanagi H
    Immune-bone interplay in the structural damage in rheumatoid arthritis.
    Clin Exp Immunol. 2018 Jul 19. doi: 10.1111/cei.13188.
    PubMed     Abstract available


  27. CECCARELLI F, Orru G, Pilloni A, Bartosiewicz I, et al
    Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients.
    Clin Exp Immunol. 2018 Jul 15. doi: 10.1111/cei.13184.
    PubMed     Abstract available


    June 2018
  28. GANG X, Xu H, Si L, Zhu X, et al
    Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast-like synoviocytes cells.
    Clin Exp Immunol. 2018 Jun 19. doi: 10.1111/cei.13161.
    PubMed     Abstract available


  29. DUNAEVA M, Blom J, Thurlings R, Pruijn GJM, et al
    Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis.
    Clin Exp Immunol. 2018 Jun 12. doi: 10.1111/cei.13156.
    PubMed     Abstract available


    March 2018
  30. AINOLA M, Porola P, Takakubo Y, Przybyla B, et al
    Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjogren's syndrome.
    Clin Exp Immunol. 2018;191:301-310.
    PubMed     Abstract available


    January 2018
  31. ZHANG Y, Wang S, Dong H, Yi X, et al
    LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-alpha stimulation.
    Clin Exp Immunol. 2018 Jan 12. doi: 10.1111/cei.13100.
    PubMed     Abstract available


  32. ALIVERNINI S, Tolusso B, Ferraccioli G, Gremese E, et al
    Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.
    Clin Exp Immunol. 2018 Jan 8. doi: 10.1111/cei.13098.
    PubMed     Abstract available


    December 2017
  33. FERRACCIOLI G, Gremese E
    B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
    Clin Exp Immunol. 2017;190:291-292.
    PubMed     Abstract available


    November 2017
  34. XU L, Hu F, Zhu H, Liu X, et al
    Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: Correlation with disease activity and bone destruction.
    Clin Exp Immunol. 2017 Nov 17. doi: 10.1111/cei.13082.
    PubMed     Abstract available


  35. LI J, Xu B, Wu C, Yan X, et al
    TXNDC5 Contributes to Rheumatoid Arthritis by Down-regulating IGFBP1 Expression.
    Clin Exp Immunol. 2017 Nov 13. doi: 10.1111/cei.13080.
    PubMed     Abstract available


    October 2017
  36. EBE H, Matsumoto I, Kawaguchi H, Kurata I, et al
    Clinical and functional significance of STEAP4-splice variant in CD14+ monocytes in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2017 Oct 28. doi: 10.1111/cei.13076.
    PubMed     Abstract available


  37. TAKAHASHI H, Tsuboi H, Asashima H, Hirota T, et al
    cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
    Clin Exp Immunol. 2017;190:96-109.
    PubMed     Abstract available


  38. ZHANG S, Huang G, Yuan K, Zhu Q, et al
    Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities.
    Clin Exp Immunol. 2017;190:29-39.
    PubMed     Abstract available


    September 2017
  39. RODRIGUEZ PC, Prada DM, Moreno E, Aira LE, et al
    The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label phase I clinical trial.
    Clin Exp Immunol. 2017 Sep 30. doi: 10.1111/cei.13061.
    PubMed     Abstract available


    August 2017
  40. TANG Y, Wang B, Sun X, Li H, et al
    Rheumatoid arthritis fibroblast-like synoviocytes cocultured with PBMC increased peripheral CD4+CXCR5+ICOS+ T cells numbers.
    Clin Exp Immunol. 2017 Aug 18. doi: 10.1111/cei.13025.
    PubMed     Abstract available


  41. BECERRA E, De La Torre I, Leandro MJ, Cambridge G, et al
    B cell phenotypes in patients with rheumatoid arthritis relapsing after Rituximab: Expression of B cell activating factor-binding receptors on B cell subsets.
    Clin Exp Immunol. 2017 Aug 11. doi: 10.1111/cei.13024.
    PubMed     Abstract available


    July 2017
  42. WEHMEYER C, Pap T, Buckley CD, Naylor AJ, et al
    The role of stromal cells in inflammatory bone loss.
    Clin Exp Immunol. 2017;189:1-11.
    PubMed     Abstract available


  43. MAMELI G, Erre GL, Caggiu E, Mura S, et al
    Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.
    Clin Exp Immunol. 2017;189:127-131.
    PubMed     Abstract available


    June 2017
  44. BOMMARITO D, Hall C, Taams LS, Corrigall VM, et al
    Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
    Clin Exp Immunol. 2017;188:455-466.
    PubMed     Abstract available


  45. SCHAPER F, de Leeuw K, Horst G, Maas F, et al
    Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Clin Exp Immunol. 2017;188:412-419.
    PubMed     Abstract available


    May 2017
  46. STUMER J, Biermann MHC, Knopf J, Magorivska I, et al
    Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Clin Exp Immunol. 2017 May 16. doi: 10.1111/cei.12987.
    PubMed     Abstract available


  47. WILLIS VC, Banda NK, Cordova KN, Chandra PE, et al
    Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.
    Clin Exp Immunol. 2017;188:263-274.
    PubMed     Abstract available


  48. AGGARWAL A, Gupta R, Negi VS, Rajasekhar L, et al
    Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
    Clin Exp Immunol. 2017;188:254-262.
    PubMed     Abstract available


    April 2017
  49. MITCHELL TS, Moots RJ, Wright HL
    JAK inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or ROS production.
    Clin Exp Immunol. 2017 Apr 2. doi: 10.1111/cei.12970.
    PubMed     Abstract available


  50. SCHINNERLING K, Aguillon JC, Catalan D, Soto L, et al
    The role of IL-6 signaling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Clin Exp Immunol. 2017 Apr 1. doi: 10.1111/cei.12966.
    PubMed     Abstract available


  51. CONTRERAS RUIZ L, Mir FA, Turpie B, Masli S, et al
    Thrombospondin-derived peptide attenuates Sjogren's syndrome-associated ocular surface inflammation in mice.
    Clin Exp Immunol. 2017;188:86-95.
    PubMed     Abstract available


    February 2017
  52. TAHARA M, Tsuboi H, Segawa S, Asashima H, et al
    RORgammat antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
    Clin Exp Immunol. 2017;187:213-224.
    PubMed     Abstract available


    December 2016
  53. APOSTOLOU E, Kapsogeorgou EK, Konsta OD, Giotakis I, et al
    Expression of type III interferons (IFNlambdas) and their receptor in Sjogren's syndrome.
    Clin Exp Immunol. 2016;186:304-312.
    PubMed     Abstract available


    October 2016
  54. RUSCITTI P, Cipriani P, Ciccia F, Di Benedetto P, et al
    H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
    Clin Exp Immunol. 2016;186:30-8.
    PubMed     Abstract available


  55. PAN ZJ, Horton CG, Lawrence C, Farris AD, et al
    Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjogren's syndrome (SS)-B.
    Clin Exp Immunol. 2016;186:18-29.
    PubMed     Abstract available


    August 2016
  56. CICCIA F, Guggino G, Ferrante A, Cipriani P, et al
    Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Clin Exp Immunol. 2016;185:125-32.
    PubMed     Abstract available


    July 2016
  57. SZITTNER Z, Bentlage AE, Rovero P, Migliorini P, et al
    Label-free detection of immune complexes with myeloid cells.
    Clin Exp Immunol. 2016;185:72-80.
    PubMed     Abstract available


    June 2016
  58. ALUNNO A, Carubbi F, Bistoni O, Caterbi S, et al
    Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjogren's syndrome: a pilot study.
    Clin Exp Immunol. 2016;184:284-92.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: